Literature DB >> 14513041

Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK cell chimaerism for late graft rejection.

S Matthes-Martin1, T Lion, O A Haas, F Frommlet, H Daxberger, M König, D Printz, D Scharner, C Eichstill, C Peters, A Lawitschka, H Gadner, G Fritsch.   

Abstract

Chimaerism of FACS-sorted leucocyte subsets (CD14+, CD15+, CD3-/56+, CD3+/4+, CD3+/8+, CD19+) was monitored prospectively between days +14 and +100 in 39 children undergoing allogeneic stem cell transplantation with reduced intensity-conditioning regimens. Cell subsets exceeding 1% of nucleated cells were subject to cell sorting. Chimaerism was analysed by dual-colour FISH and/or by short tandem repeat-polymerase chain reaction. The chimaerism pattern on day +28 was evaluated with regard to its correlation with graft rejection. Of 39 patients, nine patients had donor chimaerism (DC) in all subsets. Mixed/recipient chimaerism (MC/RC) was detectable within T cells in 62%, within NK cells in 39% and within monocytes and granulocytes in 38% of the patients. The correlation of secondary graft rejection with the chimaerism pattern on day +28 revealed the strongest association between RC in NK-cells (P<0.0001), followed by T cells (P=0.001), and granulocytes and monocytes (P=0.034). Notably, patients with RC in T cells rejected their graft only if MC or RC was also present in the NK-cell subset. By contrast, none of the children with DC in NK cells experienced a graft rejection. These observations suggest that, in the presence of recipient T-cell chimaerism, the chimaerism status in NK-cells on day +28 might be able to identify patients at high risk for late graft rejection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14513041     DOI: 10.1038/sj.leu.2403087

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  Detection and quantification of chimerism by droplet digital PCR.

Authors:  David George; Juliann Czech; Bobby John; Min Yu; Lawrence J Jennings
Journal:  Chimerism       Date:  2013-06-20

Review 2.  A practical guide to chimerism analysis: Review of the literature and testing practices worldwide.

Authors:  Amanda G Blouin; Fei Ye; Jenifer Williams; Medhat Askar
Journal:  Hum Immunol       Date:  2021-08-14       Impact factor: 2.211

Review 3.  Chimerism analysis for clinicians: a review of the literature and worldwide practices.

Authors:  Amanda G Blouin; Medhat Askar
Journal:  Bone Marrow Transplant       Date:  2022-01-26       Impact factor: 5.174

4.  Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning.

Authors:  Ran Reshef; Elizabeth O Hexner; Alison W Loren; Noelle V Frey; Edward A Stadtmauer; Selina M Luger; James K Mangan; Saar I Gill; Pavel Vassilev; Kathryn A Lafferty; Jacqueline Smith; Vivianna M Van Deerlin; Rosemarie Mick; David L Porter
Journal:  Biol Blood Marrow Transplant       Date:  2014-07-10       Impact factor: 5.742

5.  Impact of hematopoietic chimerism at day +14 on engraftment after unrelated donor umbilical cord blood transplantation for hematologic malignancies.

Authors:  Federico Moscardó; Jaime Sanz; Leonor Senent; Susana Cantero; Javier de la Rubia; Pau Montesinos; Dolores Planelles; Ignacio Lorenzo; Jose Cervera; Javier Palau; Miguel A Sanz; Guillermo F Sanz
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

6.  Indoleamine 2,3-dioxygenase in human hematopoietic stem cell transplantation.

Authors:  Birgit Jürgens; Julia Raberger; Dietmar Fuchs; Andreas Heitger
Journal:  Int J Tryptophan Res       Date:  2010-06-10

7.  Reduced intensity transplantation for primary immunodeficiency disorders.

Authors:  Paul Veys
Journal:  Pediatr Rep       Date:  2011-06-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.